Search - tctmd.com

Displaying 1 - 20 of 46

Sort: Relevancy | Date

News Daily News

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

L.A. McKeown

July 15, 2025

News Conference News CX Symposium 2025

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

L.A. McKeown

April 23, 2025

News Daily News

Survey Calls Out Implicit Bias in Peripheral Vascular Care

L.A. McKeown

February 28, 2025

News Daily News

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

L.A. McKeown

December 12, 2024

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Daily News

Amputation Risks Higher After Revascularization in Younger vs Older PAD Patients

L.A. McKeown

July 24, 2024

News Opinion CV Team Dispatch

July 2024 Dispatch for the CV Team

L.A. McKeown

July 01, 2024

News Conference News SCAI 2024

No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis

L.A. McKeown

May 10, 2024

News Conference News ACC 2024

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

Caitlin E. Cox

April 10, 2024

News Daily News

New Scientific Statement Focuses on Below-the-Knee Technical Challenges

L.A. McKeown

January 19, 2024

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

News Conference News LINC 2023

PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD

L.A. McKeown

June 21, 2023

News Conference News SCAI 2023

CLIPPER Attempts to Draw Out Useful Quality Metrics for CLTI

L.A. McKeown

May 25, 2023

News Conference News SCAI 2023

Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI

L.A. McKeown

May 24, 2023

News Daily News

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

L.A. McKeown

January 24, 2023

News Features

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

L.A. McKeown

December 02, 2022

News Conference News SCAI 2022

DISRUPT PAD III: Lithotripsy Prep Linked to Better PAD Patency at 1 Year

L.A. McKeown

May 23, 2022

The finding, from a study with a mean follow-up of 2-and-a-half years, bolsters support for trials and device use to continue.

News Daily News

SWEDEPAD: No Mortality Signal With Paclitaxel in PAD

L.A. McKeown

December 18, 2020

News Conference News VIVA 2020

BVS Reboot? Signs of Durability to 2 Years in Critical Limb-Threatening Ischemia

L.A. McKeown

November 11, 2020

News Daily News

No Long-term Mortality Risk for Paclitaxel-Based Peripheral Devices: Medicare Advantage Cohort

L.A. McKeown

June 29, 2020

Advertisement

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

Survey Calls Out Implicit Bias in Peripheral Vascular Care

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

Scientific Statement Reviews Current Antithrombotic Options in PAD

Amputation Risks Higher After Revascularization in Younger vs Older PAD Patients

July 2024 Dispatch for the CV Team

No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

New Scientific Statement Focuses on Below-the-Knee Technical Challenges

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD

CLIPPER Attempts to Draw Out Useful Quality Metrics for CLTI

Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

DISRUPT PAD III: Lithotripsy Prep Linked to Better PAD Patency at 1 Year

SWEDEPAD: No Mortality Signal With Paclitaxel in PAD

BVS Reboot? Signs of Durability to 2 Years in Critical Limb-Threatening Ischemia

No Long-term Mortality Risk for Paclitaxel-Based Peripheral Devices: Medicare Advantage Cohort

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content